Introduction
Joint wear can cause pain and limit mobility. For any material placed within a joint to be useful, it must stay where it is put. This article explains how ChondroFiller, a CE-marked Class III collagen scaffold, achieves reliable placement as a non-surgical injection — and what that means in practice for patients considering their options.
Why Secure Placement Matters
Joints are constantly in motion. A material placed within them must remain stable across the full range of everyday activity, from walking and climbing stairs to bending and turning. Traditional surgical approaches to cartilage repair rely on sutures or adhesive glues to fix grafts in position, which adds complexity and recovery burden. The ChondroFiller injection takes a different, non-surgical approach: the material adheres through its own physical and biochemical properties, without any anchoring or stitching.
How ChondroFiller Adheres Naturally
ChondroFiller is delivered as a liquid that sets into a gel within the joint in approximately three to five minutes. Like soft putty pressed into a mould, the liquid collagen flows to fill the unique three-dimensional contour of the worn area before solidifying. The resulting hydrogel forms stable bonds with endogenous fibrin present in the surrounding cartilage and subchondral bone. This intrinsic adhesiveness means the implant remains securely fixed within the defect without sutures or external fibrin glue.
The device is acellular — it contains no donor or patient cells — but it acts as a chemotactic scaffold, attracting the patient's own progenitor cells from the synovium and subchondral bone marrow into the defect, where they can differentiate and begin to lay down new cartilage matrix over time.
Stable Under Movement
Everyday activities such as walking or bending could dislodge a poorly fixed material. ChondroFiller's gel composition and the way it conforms precisely to the joint surface help it remain in place during movement. The material is collagen-based with biological potential, but it is best understood as a supportive, joint-preserving treatment rather than a cure or a reversal of arthritis. Benefits vary between patients.
Who It May Suit and What to Expect
The ChondroFiller injection may suit people with osteoarthritis or localised joint wear who want a non-surgical option. Because it is delivered as an ultrasound-guided outpatient injection — no theatre, no incision, no general anaesthetic — recovery is generally straightforward compared with surgical alternatives. Patients with larger or more complex defects, or where the anatomy is not well suited to an injection approach, may be better assessed for a surgical option such as the Liquid Cartilage protocol, in which ChondroFiller is placed arthroscopically alongside biological adjuncts during keyhole surgery.
A specialist assessment is important before any cartilage intervention. The right pathway depends on defect size, location, joint involved, and overall clinical picture.
Conclusion
ChondroFiller offers a reliable, non-surgical route to cartilage support by combining natural in-situ gelation with stable adhesion to the surrounding tissue, staying in place without stitches or anchors. It may help support a worn joint, but it is not a cure and outcomes vary. At the London Cartilage Clinic, specialist assessment helps determine whether the ChondroFiller injection or another treatment pathway is appropriate for your situation.
References
Corain, M., Zanotti, F., Giardini, M., Gasperotti, L., Invernizzi, E., Biasi, V., & Lavagnolo, U. (2023). The use of an acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis. Cartilage.
Frequently Asked Questions
- ChondroFiller is a non-surgical injection that adheres naturally within the joint through its own gel chemistry and bonds with endogenous fibrin. It stays in place without sutures or anchors. Traditional surgical grafts rely on physical fixation, which adds complexity and recovery time. ChondroFiller is not a cure, but it avoids the need for theatre or incision.
- It may add a protective, cushioning layer over worn joint surfaces, delivered without surgery and with a generally straightforward recovery. Because the collagen scaffold attracts the patient's own progenitor cells, there is biological potential for tissue repair over time. Benefits cannot be guaranteed and vary between patients.
- Its gel composition and close fit to the contours of the defect help it remain in place during everyday movement such as walking and bending. The material forms stable bonds with surrounding tissue, which means it does not need external fixation to maintain its position.
- These are two distinct pathways. The ChondroFiller injection is a non-surgical, ultrasound-guided outpatient procedure — no theatre, no anaesthetic. Liquid Cartilage is Professor Paul Lee's keyhole surgical protocol, in which ChondroFiller scaffold is placed arthroscopically alongside biological adjuncts such as platelet-rich plasma or fibrin, and where indicated the patient's own mesenchymal stem cells. Liquid Cartilage is surgery and is used for larger or more complex defects. A specialist assessment will identify which approach, if either, is appropriate.
- A thorough assessment of the joint, defect characteristics, symptoms, and overall health. The clinician will discuss whether the ChondroFiller injection, a surgical option such as Liquid Cartilage, or another approach is most likely to help — with realistic guidance on what each pathway involves and what outcomes evidence suggests.
Where to go from here
A few next steps tailored to what you have just read.
Legal & Medical Disclaimer
This article is written by an independent contributor and reflects their own views and experience, not necessarily those of London Cartilage Clinic. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.
Always seek personalised advice from a qualified healthcare professional before making decisions about your health. London Cartilage Clinic accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.
If you believe this article contains inaccurate or infringing content, please contact us at [email protected].
